Next Article in Journal
Interplay between STAT3, Cell Adhesion Molecules and Angiogenesis-Related Parameters in Gastric Carcinoma. Does STAT3 Really Have a Prognostic Value?
Previous Article in Journal
Association between P2X7 Polymorphisms and Susceptibility to Tuberculosis: An Updated Meta-Analysis of Case-Control Studies
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessReview

Exploring the Continuum of Hypertrophic Cardiomyopathy—From DNA to Clinical Expression

1
Department of Cardiology, Clinical Emergency Hospital of Bucharest, Floreasca Street 8, 014461 Bucharest, Romania
2
Department 4-Cardiothoracic Pathology, University of Medicine and Pharmacy Carol Davila, Eroii Sanitari Bvd. 8, 050474 Bucharest, Romania
3
Cardiomyopathy Center, Monza Hospital, Tony Bulandra Street 27, 021968 Bucharest, Romania
*
Author to whom correspondence should be addressed.
Medicina 2019, 55(6), 299; https://doi.org/10.3390/medicina55060299
Received: 23 March 2019 / Revised: 20 June 2019 / Accepted: 20 June 2019 / Published: 23 June 2019
  |  
PDF [1660 KB, uploaded 23 June 2019]
  |  

Abstract

The concepts underlying hypertrophic cardiomyopathy (HCM) pathogenesis have evolved greatly over the last 60 years since the pioneering work of the British pathologist Donald Teare, presenting the autopsy findings of “asymmetric hypertrophy of the heart in young adults”. Advances in human genome analysis and cardiac imaging techniques have enriched our understanding of the complex architecture of the malady and shaped the way we perceive the illness continuum. Presently, HCM is acknowledged as “a disease of the sarcomere”, where the relationship between genotype and phenotype is not straightforward but subject to various genetic and nongenetic influences. The focus of this review is to discuss key aspects related to molecular mechanisms and imaging aspects that have prompted genotype–phenotype correlations, which will hopefully empower patient-tailored health interventions. View Full-Text
Keywords: hypertrophic cardiomyopathy; causative mutations; modifiers; cardiac imaging hypertrophic cardiomyopathy; causative mutations; modifiers; cardiac imaging
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Popa-Fotea, N.M.; Micheu, M.M.; Bataila, V.; Scafa-Udriste, A.; Dorobantu, L.; Scarlatescu, A.I.; Zamfir, D.; Stoian, M.; Onciul, S.; Dorobantu, M. Exploring the Continuum of Hypertrophic Cardiomyopathy—From DNA to Clinical Expression. Medicina 2019, 55, 299.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Medicina EISSN 1010-660X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top